These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10936889)
21. p27 Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value. Feakins RM; Ghaffar AH Hum Pathol; 2003 Apr; 34(4):385-90. PubMed ID: 12733121 [TBL] [Abstract][Full Text] [Related]
22. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491 [TBL] [Abstract][Full Text] [Related]
23. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Philipp-Staheli J; Payne SR; Kemp CJ Exp Cell Res; 2001 Mar; 264(1):148-68. PubMed ID: 11237531 [TBL] [Abstract][Full Text] [Related]
24. Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome. Nitti D; Belluco C; Mammano E; Marchet A; Ambrosi A; Mencarelli R; Segato P; Lise M J Surg Oncol; 2002 Dec; 81(4):167-75; discussion 175-6. PubMed ID: 12451619 [TBL] [Abstract][Full Text] [Related]
25. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma. Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337 [TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974 [TBL] [Abstract][Full Text] [Related]
27. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Esposito V; Baldi A; De Luca A; Groger AM; Loda M; Giordano GG; Caputi M; Baldi F; Pagano M; Giordano A Cancer Res; 1997 Aug; 57(16):3381-5. PubMed ID: 9270000 [TBL] [Abstract][Full Text] [Related]
28. p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions. De Paola F; Vecci AM; Granato AM; Liverani M; Monti F; Innoceta AM; Gianni L; Saragoni L; Ricci M; Falcini F; Amadori D; Volpi A J Pathol; 2002 Jan; 196(1):26-31. PubMed ID: 11748638 [TBL] [Abstract][Full Text] [Related]
29. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer. Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548 [TBL] [Abstract][Full Text] [Related]
30. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477 [TBL] [Abstract][Full Text] [Related]
31. Cell cycle dysregulation influences survival in high risk breast cancer patients. Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474 [TBL] [Abstract][Full Text] [Related]
32. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1). Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789 [TBL] [Abstract][Full Text] [Related]
33. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847 [TBL] [Abstract][Full Text] [Related]
34. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer. Vis AN; van Rhijn BW; Noordzij MA; Schröder FH; van der Kwast TH J Pathol; 2002 Jun; 197(2):148-54. PubMed ID: 12015737 [TBL] [Abstract][Full Text] [Related]
35. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303 [TBL] [Abstract][Full Text] [Related]
36. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Migita T; Oda Y; Naito S; Tsuneyoshi M Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465 [TBL] [Abstract][Full Text] [Related]
37. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944 [TBL] [Abstract][Full Text] [Related]
38. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1). Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization. Palmqvist R; Stenling R; Oberg A; Landberg G J Pathol; 1999 May; 188(1):18-23. PubMed ID: 10398135 [TBL] [Abstract][Full Text] [Related]
40. Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum--a comparative clinicopathologic and molecular analysis. Hirano K; Minamoto T Cancer Detect Prev; 2000; 24(4):343-55. PubMed ID: 11059565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]